Kirk Falconer

Newbury Partners is marketing a fifth secondaries offering with a target of $1.75 billion and a hard cap of $2 billion, Buyouts reported last November.

Blackstone's global head of private equity speaks exclusively to Buyouts about the firm's long-hold strategy. Blackstone raised $8.2bn for its second offering, 70% more than the strategy’s 2016-vintage debut fund.

L Catterton will stay on the fundraising trail to give limited partners time to complete allocations, a source told Buyouts. The offering is expected to close in early 2021.

Private equity energy investors embrace the promise but also the challenges of the transition from fossil fuels to the burgeoning renewables movement.

Fund II’s close may be helped along by Amulet's recent agreement to sell Synteract to Syneos Health, which is expected to generate a more than 4x multiple and 40 percent gross IRR.

CEO Jeffry Brown, a former Dyal Capital Partners principal, expects to see bolt-on strategies in use over the next five years, especially as mid-market firms increasingly transact with GP stakes funds.

Ascend was founded in 2019 by In Seon Hwang, formerly global head of healthcare at Warburg Pincus, and Richard Park, ex-CEO of Warburg portfolio company CityMD.

US and Canadian buyout, growth equity, secondaries, venture capital and other PE funds collected $200bn at the end of September, down 25% from the same time last year.

Rise Fund II is already larger than its predecessor, which closed in 2017 at $2.1bn, becoming one of the world’s largest dedicated pools for impact investing.

Brightstar in September announced Fund II’s debut deal, the acquisition of a majority stake in SoftBank's mobile device services business Brightstar Corp.